LU75229A1 - - Google Patents

Info

Publication number
LU75229A1
LU75229A1 LU75229A LU75229A LU75229A1 LU 75229 A1 LU75229 A1 LU 75229A1 LU 75229 A LU75229 A LU 75229A LU 75229 A LU75229 A LU 75229A LU 75229 A1 LU75229 A1 LU 75229A1
Authority
LU
Luxembourg
Application number
LU75229A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75229A1 publication Critical patent/LU75229A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75229A 1975-06-25 1976-06-24 LU75229A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528879 DE2528879A1 (de) 1975-06-25 1975-06-25 11 beta-fluor-androstene

Publications (1)

Publication Number Publication Date
LU75229A1 true LU75229A1 (en:Method) 1977-02-18

Family

ID=5950147

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75229A LU75229A1 (en:Method) 1975-06-25 1976-06-24

Country Status (8)

Country Link
JP (1) JPS523050A (en:Method)
BE (1) BE843437A (en:Method)
DD (1) DD124988A5 (en:Method)
DE (1) DE2528879A1 (en:Method)
DK (1) DK252276A (en:Method)
FR (1) FR2316958A1 (en:Method)
LU (1) LU75229A1 (en:Method)
NL (1) NL7606822A (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439487A (en) * 1982-12-17 1984-03-27 E. I. Du Pont De Nemours & Company Polyester/nylon bicomponent flament

Also Published As

Publication number Publication date
DE2528879A1 (de) 1977-01-13
BE843437A (fr) 1976-12-27
JPS523050A (en) 1977-01-11
FR2316958A1 (fr) 1977-02-04
DD124988A5 (en:Method) 1977-03-23
NL7606822A (nl) 1976-12-28
DK252276A (da) 1976-12-26

Similar Documents

Publication Publication Date Title
JPS5623232B2 (en:Method)
FR2308157B1 (en:Method)
AU495829B2 (en:Method)
JPS5310062B2 (en:Method)
JPS51124557U (en:Method)
JPS51163226U (en:Method)
JPS5342335B2 (en:Method)
JPS51163490U (en:Method)
JPS51160236U (en:Method)
JPS5224843U (en:Method)
JPS5216701U (en:Method)
JPS5513581Y2 (en:Method)
JPS5433649Y2 (en:Method)
JPS5712573Y2 (en:Method)
FR2319711B1 (en:Method)
JPS5197006U (en:Method)
JPS5238946U (en:Method)
JPS51161903U (en:Method)
JPS51117608U (en:Method)
BG22430A1 (en:Method)
CH589274A5 (en:Method)
CH599808A5 (en:Method)
CH599805A5 (en:Method)
BG22256A1 (en:Method)
CH599674A5 (en:Method)